Perlu Network score measures the extent of a member’s network on Perlu based on their connections, Packs, and Collab activity.
Revolutionizing the Drug Discovery Marketplace with Kevin Lustig, Founder and CEO, Scientist.com Biotech 2050 Podcast: Revolutionizing the Drug Discovery Marketplace with Kevin Lustig, Founder and CEO, Scientist.com Listen in as CEO and Founder Kevin Lustig, PhD, was featured on the Biotech 2050 podcast, a think tank chronicling the disruptions changing the biotech industry over the next several decades. Biotech 2050 is co-hosted by Alok Tayi, PhD, VP of Life Sciences at Egnyte and Rahul Chaturvedi, Founder and CEO of Clora. Revolutionizing the Drug Discovery Marketplace with Kevin Lustig, Founder and CEO, Scientist.com Scientist.com to Acquire HealthEconomics.
In this post I tried to summarize pretty much all small-scale companies (mostly startups), who offer artificial intelligence (AI)-driven computational tools and services for the key stages of a drug discovery pipeline. We use cookies for various purposes including to make your experience of our website better. Please confirm below that you consent to our use of non-essential cookies in accordance with our cookies policy. Click here to access our cookies policy and find out more about our cookie use and how to disable cookies.